Synjardy 5 mg/1

Synjardy 5 mg/1 tablets combine empagliflozin and metformin hydrochloride for managing type 2 diabetes. This oral medication supports blood sugar control as part of a broader treatment plan. Learn about Synjardy's uses, effects, and precautions.

Synjardy 5 mg/1 tablets are used to improve glycemic control in adults with type 2 diabetes. This combination medication works by addressing insulin resistance and promoting glucose excretion. What is Synjardy used for? It is typically prescribed alongside diet and exercise to manage blood sugar levels effectively.

Common effects of Synjardy 5 mg/1 tablets may include gastrointestinal discomfort, such as nausea or diarrhea. Some users also report urinary tract infections or hypoglycemia, especially when combined with other diabetes medications. Individual responses can vary.

Synjardy 5 mg/1 tablets should be used with caution in patients with kidney issues or a history of pancreatitis. Regular monitoring of blood sugar levels and kidney function is recommended. Always consult a healthcare provider before starting this medication.

Synjardy 5 mg/1 tablets may interact with certain medications, including diuretics, insulin, and other diabetes drugs. Alcohol consumption should be limited, as it can increase the risk of hypoglycemia. Inform your healthcare provider about all medications you are taking.